HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination.

AuthorsDanit Maor, Sarah Brennand, Michelle Sy Goh, Vanessa Fahey, Sepehr N Tabrizi, Alvin H Chong
JournalThe Australasian journal of dermatology (Australas J Dermatol) Vol. 59 Issue 2 Pg. 147-148 (May 2018) ISSN: 1440-0960 [Electronic] Australia
PMID28718200 (Publication Type: Case Reports, Letter)
Chemical References
  • Adjuvants, Immunologic
  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Keratolytic Agents
  • Tretinoin
  • Acitretin
  • Imiquimod
Topics
  • Acitretin (therapeutic use)
  • Adjuvants, Immunologic (therapeutic use)
  • Drug Therapy, Combination
  • Epidermodysplasia Verruciformis (drug therapy, etiology)
  • Female
  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (therapeutic use)
  • Humans
  • Imiquimod (therapeutic use)
  • Immunosuppression Therapy (adverse effects)
  • Keratolytic Agents (therapeutic use)
  • Kidney Transplantation
  • Middle Aged
  • Tretinoin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: